A 52‐week update of a multicentre Italian real‐world experience on effectiveness and safety of dupilumab in adolescents with moderate‐to‐severe atopic dermatitis

Luca Stingeni(University of Perugia), Leonardo Bianchi, Luca Bianchi(University of Rome Tor Vergata), Filomena Russo(University of Siena), Massimo Gola(University of Florence), Maddalena Napolitano(University of Molise), Maria Esposito(University of North Carolina at Chapel Hill), Andrea Chiricozzi(Università Cattolica del Sacro Cuore), Elena Sofia Caroppo(University of Perugia), Claudio Feliciani(University of Parma), Mariateresa Rossi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Tommaso Bianchelli(Istituti di Ricovero e Cura a Carattere Scientifico), Annamaria Offidani(Marche Polytechnic University), Carlotta Gurioli(University of Bologna), Gabriella Fabbrocini(Universitätsklinik für Chirurgie Wien), Enzo Errichetti(University of Udine), Fabrizio Guarneri(University of Messina), Paola Savoia(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Anna Belloni Fortina(University of Padua), Giovanna Malara(Azienda ospedaliera "Bianchi-Melacrino-Morelli"), Marta Tramontana(University of Perugia), Anna Balato(University of Campania "Luigi Vanvitelli"), Michela Ortoncelli, Cataldo Patruno(Magna Graecia University), Donatella Schena(University of Verona), Monica Corazza(University of Ferrara), Eustachio Nettis(University of Bari Aldo Moro), Caterina Foti(University of Bari Aldo Moro), Marco Romanelli(University of Pisa), Giuseppe Micali(University of Catania), Silvia Mariel Ferrucci(University of Milan), Laura Bonzano(Ospedale Santa Maria), Nicola Milanesi(University of Florence), Katharina Hansel(University of Ferrara), Ketty Peris(Università Cattolica del Sacro Cuore), Giovanni Pellacani(Sapienza University of Rome), Elettra Antonelli(University of Perugia)
Journal of the European Academy of Dermatology and Venereology
October 13, 2022
Cited by 21


Related Papers